Finding the best prices at pharmacies near you...


Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Chronic obstructive pulmonary disease (COPD) is the collective name for a number of lung conditions that cause difficulties in a patient's breathing. Symptoms include shortness of breath, a chronic cough, wheezing, coughing up mucus, tightness in the chest, lethargy and unintended weight loss. 

The condition is particularly common among smokers and includes emphysema and chronic bronchitis. Chronic bronchitis is a chronic inflammation in the lining of the bronchial tubes. Emphysema is a long-term progressive lung disease that occurs when alveoli are gradually degraded, which has an adverse impact on the exchange of gases in the lungs. 

COPD is irreversible, but treatment can help control symptoms and may prevent further damage. Left untreated, the condition may lead to further serious complications, including: lung cancer, heart problems, high blood pressure and dangerous infections in the respiratory system. 

Physicians diagnosing COPD may order a range of tests, such as CT scans, chest x-rays, arterial blood gas analyses and pulmonary function tests. Oxygen therapy, pulmonary rehabilitation programs and a yearly flu vaccination may also be recommended for patients with COPD.  

Doctors will recommend cessation of smoking and may prescribe medication to alleviate breathing problems. Drug classes often used to treat COPD include: PDE4 inhibitors; plain anticholinergic inhalants; beta agonists; and anticholinergic combinations with B2-stimulants.

Products Related to Chronic Obstructive Pulmonary Disease (COPD):


Drugs Used to Treat Chronic Obstructive Pulmonary Disease (COPD):

Systemic Corticosteroids, Plain
Asthma, Rheumatoid Arthritis, Psoriasis, Allergic Conjunctivitis, Anaphylaxis, Crohn's Disease.
Anticholinergics-plain, Inhalant
Asthma, chronic obstructive pulmonary disease (COPD), emphysema.
Systemic Corticosteroids, Plain
Asthma, Eczema, Leukemia, Lupus, Psoriasis, Multiple Sclerosis.
Short-acting B2-stimulants, Inhalant
Asthma, chronic obstructive pulmonary disease (COPD).
Short-acting B2-stimulants, Inhalant
Asthma, chronic obstructive pulmonary disease (COPD).

Drugs Related to Chronic Obstructive Pulmonary Disease (COPD):

Systemic Corticosteroids, Plain
Asthma, Rheumatoid Arthritis, Psoriasis, Allergic Conjunctivitis, Anaphylaxis, Crohn's Disease.
Anticholinergics-plain, Inhalant
Asthma, chronic obstructive pulmonary disease (COPD), emphysema.
Systemic Corticosteroids, Plain
Asthma, Eczema, Leukemia, Lupus, Psoriasis, Multiple Sclerosis.
Short-acting B2-stimulants, Inhalant
Asthma, chronic obstructive pulmonary disease (COPD).
Short-acting B2-stimulants, Inhalant
Asthma, chronic obstructive pulmonary disease (COPD).
Short-acting B2-stimulants, Inhalant
chronic obstructive pulmonary disease (COPD).
Short-acting B2-stimulants, Inhalant
Asthma, bronchospasm prophylaxis, chronic obstructive pulmonary disease (COPD), emphysema.
Anticholinergic Combinations with B2-stimulants, Inhalant
chronic obstructive pulmonary disease (COPD).
Anticholinergics/Antispasmodics for Functional Bowel Disorders
Duodenal Ulcer, Peptic Ulcer, cholinesterase inhibitor-induced muscarinic effects prophylaxis, sialorrhea, bradycardia, aspiration prophylaxis.
Systemic Corticosteroids, Plain
Asthma, Eczema, Leukemia, Lupus, Psoriasis, Multiple Sclerosis.
PDE4 Inhibitors For Asthma/COPD, Systemic
chronic obstructive pulmonary disease (COPD).
Anticholinergics-plain, Inhalant
chronic obstructive pulmonary disease (COPD).
Combinations of B2-stimulants with Corticosteroids, Inhalant
Asthma, chronic obstructive pulmonary disease (COPD), emphysema.
Combinations of B2-stimulants with Corticosteroids, Inhalant
chronic obstructive pulmonary disease (COPD).
Anticholinergic Combinations with B2-stimulants, Inhalant
chronic obstructive pulmonary disease (COPD).
Combinations of B2-stimulants with Corticosteroids, Inhalant
chronic obstructive pulmonary disease (COPD).
Anticholinergics-plain, Inhalant
chronic obstructive pulmonary disease (COPD), emphysema.
Systemic Corticosteroids, Plain
Asthma, Eczema, Gout, Psoriasis, Multiple Sclerosis, Allergic Conjunctivitis.
Long-acting B2-stimulants, Inhalant
chronic obstructive pulmonary disease (COPD), emphysema.
Anticholinergics-plain, Inhalant
Asthma, chronic obstructive pulmonary disease (COPD), emphysema.
Anticholinergic Combinations with B2-stimulants, Inhalant
chronic obstructive pulmonary disease (COPD).
Anticholinergics-plain, Inhalant
allergic rhinitis, common cold, rhinorrhea, bronchospasm prophylaxis, chronic obstructive pulmonary disease (COPD), emphysema.
Topical Anti-hemorrhoidals with Corticosteroids
Psoriasis, Hemorrhoids, insect bites or stings, polymorphous light eruption, Rhus dermatitis, alopecia.

chronic obstructive pulmonary disease (COPD).
Systemic Corticosteroids, Plain
Asthma, Eczema, Gout, Psoriasis, Multiple Sclerosis, Allergic Conjunctivitis.
Anticholinergic Combinations with Other, Inhalant
chronic obstructive pulmonary disease (COPD).
Systemic Corticosteroids, Plain
Addison's disease.
Systemic Corticosteroids, Plain
Asthma, Rheumatoid Arthritis, Psoriasis, Allergic Conjunctivitis, Chronic ITP, Crohn's Disease.
Systemic Corticosteroids, Plain
Asthma, Eczema, Psoriasis, Multiple Sclerosis, Allergic Conjunctivitis, Anaphylaxis.
Systemic Corticosteroids, Plain
Asthma, Eczema, Psoriasis, Multiple Sclerosis, Allergic Conjunctivitis, Anaphylaxis.
Mucolytics
Acetaminophen Overdose.
Systemic Corticosteroids, Plain
Asthma, Eczema, Gout, Psoriasis, Multiple Sclerosis, Allergic Conjunctivitis.
Plain Topical Corticosteroids
Asthma, Eczema, Psoriasis, Allergic Conjunctivitis, allergic rhinitis, polymorphous light eruption.

Asthma, Rheumatoid Arthritis, Psoriasis, Allergic Conjunctivitis, Anaphylaxis, Crohn's Disease.
Short-acting B2-stimulants, Inhalant
Asthma, bronchospasm prophylaxis, chronic obstructive pulmonary disease (COPD), emphysema.

Asthma, Eczema, Gout, Psoriasis, Multiple Sclerosis, Allergic Conjunctivitis.
Xanthines, Plain
Asthma, bronchospasm prophylaxis, chronic obstructive pulmonary disease (COPD), emphysema.
Xanthines, Plain
Asthma, bronchospasm prophylaxis, chronic obstructive pulmonary disease (COPD), emphysema.
Xanthines, Plain
Asthma.
Xanthines, Plain
Asthma, status asthmaticus, bronchospasm prophylaxis, chronic obstructive pulmonary disease (COPD), emphysema.
Xanthines, Plain
Asthma, status asthmaticus, bronchospasm prophylaxis, chronic obstructive pulmonary disease (COPD), emphysema.
Electrolytes with Carbohydrate Solutions
Asthma, Hyperkalemia, Hypoglycemia, status asthmaticus, bronchospasm prophylaxis, chronic obstructive pulmonary disease (COPD).

Asthma, Rheumatoid Arthritis, Psoriasis, Multiple Sclerosis, Allergic Conjunctivitis, Anaphylaxis.
Long-acting B2-stimulants, Inhalant
chronic obstructive pulmonary disease (COPD), emphysema.
Anticholinergic Combinations with B2-stimulants, Inhalant
chronic obstructive pulmonary disease (COPD).
Anticholinergics-plain, Inhalant
chronic obstructive pulmonary disease (COPD).
Long-acting B2-stimulants, Inhalant
chronic obstructive pulmonary disease (COPD).
Anticholinergic Combinations with B2-stimulants, Inhalant
chronic obstructive pulmonary disease (COPD).
Long-acting B2-stimulants, Inhalant
chronic obstructive pulmonary disease (COPD).
Anticholinergic Combinations with B2-stimulants, Inhalant
chronic obstructive pulmonary disease (COPD).

Blog Posts Related to Chronic Obstructive Pulmonary Disease (COPD):

Top 6 Important FDA Approvals from 2017

Over the course of 2017, the number of approvals granted by the US Food and Drug Administration (FDA) reached a 21-year high. More than 1,000 generic drugs were approved by the agency, according to FDA Commissioner Scott Gottlieb, MD, while first-time generic drug approvals numbered 74. Novel drug...

Read More

FDA approves first nebulized LAMA treatment for COPD

The US Food and Drug Administration (FDA) has approved Sunovion’s Lonhala Magnair (glycopyrrolate), making it the first nebulized long-acting muscarinic antagonist (LAMA) treatment in the United States for patients with chronic obstructive pulmonary disease (COPD). It is expected to appear in...

Read More

Tobacco products ‘still used by 20% of American adults’

Around 49 million American adults were still using tobacco products in 2015, according to new data published by the Centers for Disease Control and Prevention (CDC) and the US Food and Drug Administration’s (FDA) Center for Tobacco Products.  The Morbidity and Mortality Weekly Report...

Read More

Trelegy Ellipta: Triple therapy inhaler for COPD approved by FDA

The US Food and Drug Administration (FDA) has approved a new once-daily single inhaler triple therapy for treatment of certain adults with chronic obstructive pulmonary disease (COPD).  Trelegy Ellipta (furoate, umeclidinium, vilanterol) is indicated for patients on a fixed-dose combination...

Read More

COPD patients with Medicare Part D 'struggle with inhaler costs'

Many patients with chronic obstructive pulmonary disease (COPD) who have Medicare Part D struggle to pay for medication and inhalers, it has been suggested. A report published in the Journal of the American Medical Association (JAMA) revealed one in nine Medicare beneficiaries have COPD. The...

Read More

GSK recalls 593,000 Ventolin HFA 200D Inhalers

GlaxoSmithKline (GSK) has issued a voluntary Class II recall for three batches of its Ventolin HFA 200D inhalers, totaling over 593,000 units. The recall only affects hospitals, pharmacies, wholesalers and retailers and will not require patients to return their medication. Ventolin inhalers are...

Read More